01-lcms solutions for drug research in the pharmaceutical

LCMS solutions

2008

LCMS solutions for drug research in the pharmaceutical industry

Agilent Technologies

LC MS solutions

2008

LCMS along the drug research process

HTS, Assaydevelopment

Lead optimization

Clinical Trials Formulation Manufacturing

QA/QC

Identification of natural products

ingredients

High throughput

library screening

MS directed Purification

and preparative LC

High Throughput Tox assays

With Biotrove and QQQ

Metabolite Identification with

QTOF

ADME studies QQQ

PK and ADME studies with

QQQ

Degradation studies with

Ion trap

Impurities analysis with

TOF

UV based manufacturing

control

Extractables with single quadrupole

LC MS solutions

2008

6140 fast scanning Single QuadrupoleMaximizing Chromatographic and MS Performance

min0.1 0.2 0.3 0.4 0.5 0.6 0.7

mAU

-5

0

5

10

15

20

25

DAD1 A, Sig=272,4 Ref=360,80 (G:\CHEM32 DATA\ASMS\ULTRASCPNMM0002.D)

0.149

0.250 0.4

32

0.668

min*0.1 0.2 0.3 0.4 0.5 0.6 0.7

0

20000

40000

60000

80000

100000

120000

140000*MSD1 BPC, MS File (G:\CHEM32 DATA\ASMS\ULTRASCPNMM0002.D) MM-ES+APCI, Fast Scan, Frag: 100, "PosScan"

0.149

0.251

0.432

0.667

min*0.1 0.2 0.3 0.4 0.5 0.6 0.70

5000

10000

15000

2000025000

30000

35000

40000*MSD2 BPC, MS File (G:\CHEM32 DATA\ASMS\ULTRASCPNMM0002.D) MM-ES+APCI, Fast Scan, Frag: 100, "NegScan"

0.150

0.251

0.432

0.668

UV 254 nm

Pos MultimodeES+APCI

Neg MultimodeES+APCI

0.91 sec FWHM9 scans/sec

0.87 sec FWHM9 scans/sec

0.95 sec FWHM4.5 spectra/sec

284 286 288

286.

0

286.

8

284.

8

284 286 288

286.

0

286.

8

284.

8 Proper chlorine isotope pattern

282 284 286

284.

0

284.

8

282.

8

282 284 286

284.

0

284.

8

282.

8 Proper chlorine isotope pattern

Analytes: Sulfamethizole, Sulfachloropyridizine, Sulfamethazine, SulfadimethoxineMultimode Source Zorbax2.1 x 50mm, 1.8µM Flow Rate: 1.3 mL/min

Assay , HTS,purification

Lead optimization


QA/QC

LC MS solutions

2008

Early drug discovery applications – Identification of Ginseng extract ingredients with 6210 TOF MS

Natural products

Lead optimization


QA/QC

O

CH3OH

CH3CH3

CH3

CH3

CH3 CH3

O

O CH3

O

O

O

OHOH

OH

O

OH

OHOH

OH

OHOH

OH

O

OH

OHOH

OH

LC MS solutions

2008

Accurate mass measurement of Ginsenoside Rb1 and its CID fragments by ESI TOF O

CH3OH

CH3CH3

CH3

CH3

CH3 CH3

O

O CH3

O

O

O

OHOH

OH

O

OH

OHOH

OH

OHOH

OH

O

OH

OHOH

OH 425.3784

C30H49O = 425.3784-H2OC30H47 = 407.3679

785.5047

325.1136

343.1248

C42H73O13 = 785.5047-H2OC42H71O12 = 767.4950-H2OC42H69O11 = 749.4850

100 150 200 250 300 350 400 450 500 550 600 650 700 750 800 850 900 9501000105011001150m/z, amu0.0

2.0e44.0e46.0e48.0e41.0e51.2e51.4e51.6e51.8e52.0e52.2e52.4e52.6e52.8e53.0e53.2e53.4e53.6e53.8e54.0e54.2e54.4e54.6e54.8e55.0e5

Intensity, counts

425.3784

407.3679

1109.6129

325.1136

785.5047

767.4950

749.4854

343.12481091.6012

-0.911.00C54H91O221091.60021091.6012

2.230.80C12H23O11343.1240343.1248-0.300.10C30H47407.3678407.3679

-0.390.10C12H21O10325.1135325.1136

0.53-0.40C42H73O13785.5051785.5047-0.580.40C42H71O12767.4946767.49501.88-1.40C42H69O11749.4840749.4854-0.140.10C30H49O425.3783425.3784

-1.902.10C54H93O231109.61081109.6129

Mass accuracy [ppm]

Mass accuracy [mDa]FormulaCalculated

massMeasured mass

Natural products

Lead optimization


QA/QC

LC MS solutions

2008

Early drug discovery applications: High Throughput Chemical Library Screening with 6210 TOFAnalysis of 140 real compounds under ultra-fast LC conditions (90 s cycle time 1000 samples/day):

HTS Lead optimization


QA/QC

0

5

10

15

20

25

30

-5.0

-4.5 -4.0

-3.5

-3.0

-2.5

-2.0

-1.5

-1.0

-0.5 0.0 0.5 1.0 1.5 2.0 2.5 3.0 3.5

91% within ±2.0 ppm

ppm

n pe

r 0.25

ppm

71% within ±1.0 ppm

LC MS solutions

2008

MS/MS and MS3 fragmentation for structure elucidation of ginsenosides with 6310 Ion Trap MS

Purification Lead optimization


QA/QC

365.1

789.5+MS2(1131.4), 17.8min

02467x10

Intens.

200 400 600 800 1000 m/z365.1 +MS3(1131.4->789.5), 17.8min

0123456x10

Intens.

200 400 600 800 1000 m/z

O

C H 3O H

C H 3C H 3

C H 3

C H 3

CH 3 C H 3

O

O C H 3

O

O

O

O HOH

OH

O

O H

O HOH

OH

O HOH

O H

O

O H

O HOH

OH 365.1 789.5

365.1

22 24 26 28 30 32 34 36 Time [min]

0.250.500.751.001.25

7x10Intens.

TIC +All MS

0

ReRg1 Rf

Rb1 RcRb2

Rd

38

LC MS solutions

2008

Early drug discovery applicationsMS directed Purification and preparative LC

Purification Lead optimization


QA/QC

• 2 preparative pumps• Dual-loop autosampler• ZORBAX preparative

column• MWD (DAD)• 1-3 fraction collector

PS• 6110, 6120 SQ

with active splitter

LC MS solutions

2008

Early drug discovery applicationsfast and easy to use synthesis check with Easy Access softwareEasy Access A.05.01 + Data Browser

Easy Sample Submission, Advanced Scheduling

Overlapped Injection Mode for High-Throughput

Support of CTC AutosamplerEmailing of ChemStation reports as

PDF’s

HTS Lead optimization


QA/QC

1.00.2 0.4 0.6 0.8

0.16

1

0.34

60.

400

0.51

0

0.57

5

0.63

00.

658

0.82

7

1.00.2 0.4 0.6 0.8

0.34

60.

400

0.51

0

0.57

6

0.63

00.

657

0.82

6

Run 1 Run 2

Date acquired : Wed May 16 11:18:46 2007Date acquired : Wed May 16 11:19:56 2007Date acquired : Wed May 16 11:21:06 2007Date acquired : Wed May 16 11:22:16 2007Date acquired : Wed May 16 11:23:27 2007

10 seconds inter run time

LC MS solutions

2008

Drug discovery MS applicationsDifferent Assays on 6410 QQQ• Human Liver Microsome (HLM) Stability to estimate the rate of metabolization• Plasma Protein Binding (PPB) to estimate the distribution of the drug• Caco-2-Permability (Caco-2) required as well to estimate the distribution

Assaydevelopment

Lead optimization


QA/QC

10 Compounds10 Compounds

6 Controls6 Controls

3 Assays3 Assays

121 individual samples121 individual samples

2 ISTDs2 ISTDs

18 MRM Transitions & OptimizationsPooling of samples

490 individual concentration values plus blanks, in Triplicates> 1500 data points 14 MS methods

HLM

PPBCaco-2

LCMS solutions

2008

6410 QQQ system overview

• 2 Binary Pumps SL• CTC HTC-Pal autosampler with active wash station and cooled stack• Thermostatted Column Compartement SL with 2ps/10pt valve for

Alternating Column Regeneration• 2 Agilent Zorbax RRHT SB C18 2.1mm x 50 mm, 1.8µm columns • 6410 Triple Quadrupol MS• MassHunter Software for Acquisition, Qualitative and Quantitative

Data Analysis

Assaydevelopment

Lead optimization


QA/QC

LC MS solutions

2008

Ultra high throuput assays together with Rapid Fire systemCYP 450 assay from HLM

Assaydevelopment

Lead optimization


QA/QC

LC MS solutions

2008

Metabolic stability with 6210 TOF and automatted MSMS optimization with 6410 QQQ

Assaydevelopment

Lead optimization


QA/QC

0V 5V 10V15V20V25V30V35V40V45V50V

0V5V 10V15V20V25V30V35V40V45V50V

EIC 386.3

EIC 386.3 122.0

Metabolic Stability of Buspirone

0

10

20

30

40

50

60

70

80

90

100

0 10 20 30 40Incubation Time [min]

Perc

enta

ge o

f Rem

aini

ng T

est C

ompo

und

[%]

0V 5V 10V15V20V25V30V35V40V45V 50V

0V 5V 10V15V20V25V30V35V40V45V 50V

EIC 386.3

EIC 386.3 122.0

MS&MS at 35V CE

LC MS solutions

2008

Drug discovery MS applicationsMetabolite Identification with 6510 QTOF

Assaydevelopment

Lead optimization


QA/QC

NN

NO

CH3

N

N

OCl

OH

C15H20N3O3 hydroxylated metabolite290.1500

C15H20N3O2 parent drug274.1550

LC MS solutions

2008

Metabolite ID software patented interweaved algorithms for automation

Assaydevelopment

Lead optimization


QA/QC

Metabolites

Compound Correlation

CpdList

Cpd

MFE

Compound Correlation

CpdList

MFE

Fragment Pattern Matching

…

MS/MS

Isotopic Pattern Matching

…

MS

Isotopic Pattern Matching

…

MS

EIC of expected masses

256

129

83

401



256

129

83

401

UV Chrom.

UV Chrom.

Built -in Biotransf.

–C2H +O+O2

+H-F–H2O

Built -in Biotransf.

–C2H4+O+O

–H2O…

Molecular Formula assignment

C12 H14 N9 ClC13 H23 N3 P S ClC14 H24 N2 S2 ClC14 H22 N O3 S ClC14 H16 N6 O ClC15 H25 O P S ClC16 H19 N3 P ClC17 H20 N2 S ClC18 H21 O P Cl

Molecular Formula assignment

C12 H14 N9 ClC13 H23 N3 P S ClC14 H24 N2 S2 ClC14 H22 N O3 S ClC14 H16 N6 O ClC15 H25 O P S ClC16 H19 N3 P ClC17 H20 N2 S ClC18 H21 O P Cl

Molecular structure elucidation

10

5

1

4

2

3

98

67

14

12

15

13

16

1711

CH319H

H

H

H

CH318

98

CH37

14

12

15

13

16

1711

23

2022

2425

NH28 26

H

HCH321 H

CH327H

CH318

10

5

1

4

2

3

98

67

14

12

15

13

16

1711

CH319H

H

H

H

CH318

98

CH37

14

12

15

13

16

1711

23

2022

2425

NH28 26

H

HCH321 H

CH327H

CH318

RAD Chrom.

RAD Chrom.

Metabolite Prediction

ONO

FF

F

N SO

NOO N

O

ON

OFF

F

N S

ON

OO NO

ON

OF

F

F

N S

ON

OO

m/z 568, major

ON

OF

F

F

N SO

NOO

m/z 554, major

ON

OFFF

N S

ON

OON

O

O

m/z 625, major

m/z 655, 2 in rat species

Parent, [M+H]+m/z 639

ON

OFF

F

N

m/z 341, major

ON

OFFF

N S

ON

OON

O

ON

OF

F

F

N S

ON

OON

O

m/z 611

m/z 597

ON

OFF

F

N SO

NOO

O

m/z 584

ON

OF

F

F

N S

ON

OO

O

m/z 570

ON

OFF

F

N S

ON

OO NO

Om/z 641

ONO

FF

F

N S

ON

OO

m/z 540

- CH2

- CH2

- CH2

+ O2

- CH2

+ O2

+ O2

Mass defect filter

Metabolites

LC MS solutions

2008

New Ultra High Speed Acquisition

• 4 GHz (8 bit) Analog-Digital-Converter ADC– Adapted from Agilent High Speed

Oscilloscope Systems

• Ultra High Speed FPGA Processors and Memory– 4Ghz peak detection– 4Ghz gain scaling – Up to 20,000 m/z depth

• Dual Input / Dual Gain High Bandwidth Input Amplifier for Extended Dynamic Range

Picture of 4GHz boardGoes here

FPGAs

Dual Input Amplifier

4 GHz ADC

LC MS solutions

2008

Enhanced Resolving Power –High Mass Accuracy for Isobars over Wide Dynamic Range

Methyl 5-acetyl-salicylate (MAS)[M+H]+ 195.065185

Butyl paraben (BP)[M+H]+ 195.101571

Counts (%) vs. Mass-to-Charge (m/z)195.02 195.04 195.06 195.08 195.1 195.12 195.14 195.16 195.18 195.2 195.22

0

0.25

0.5

0.75

1

1.25

1.5

1.75

2

2.25

2.5

2.75

3

3.25

3.5

3.75

4

4.25

4.5

4.75

5

5.25

5.5

5.75

6

6.25

6.5

6.75

7

7.25

7.5

7.75

8

8.25

8.5

8.75

9

9.25

9.5

+ Scan (# 3-7, 5 scans) MAS_BP_1_128.d

Counts (%) vs. Mass-to-Charge (m/ z)195.02 195.04 195.06 195.08 195.1 195.12 195.14 195.16 195.18 195.2 195.22

Zoom view128x dilution

+1.3 ppm

-1.4 ppm

-0.8 ppm

-0.2 ppm

Counts (%) vs. Mass-to-Charge (m/z)194.94 194.96 194.98 195 195.02 195.04 195.06 195.08 195.1 195.12 195.14

-1x10

0

0.2

0.4

0.6

0.8

1

1.2

1.4

1.6

1.8

2

2.2

2.4

2.6

2.8

3

3.2

3.4

3.6

3.8

4

4.2

4.4

4.6

4.8

5

5.2

5.4

5.6

5.8

6

6.2

6.4

6.6

6.8

7

+ Scan (# 3-7, 5 scans) BP_MAS_1_128.d

Counts (%) vs. Mass-to-Charge (m/ z)194.94 194.96 194.98 195 195.02 195.04 195.06 195.08 195.1 195.12 195.14

Zoom view128x dilution

+0.5 ppm0.0 ppm

+1.9 ppm

+0.7 ppm

O

OH

OO O

O

OH

Dilute MAS, keep BP constant Keep MAS constant, dilute BP

LC MS solutions

2008

Drug development LC MS applications6410 QQQ for PK applications

• 2 Binary Pumps SL• CTC HTC-Pal autosampler with active wash station and cooled stack• Thermostatted Column Compartement SL with 2ps/10pt valve for

Alternating Column Regeneration• 2 Agilent Zorbax RRHT SB C18 2.1mm x 50 mm, 1.8µm, resp. Agilent

Zorbax RR SB C18 2.1mm x 50 mm, 3.5µm columns• 6410 Triple Quadrupole MS• MassHunter Software for Acquisition, Qualitative and Quantitative Data

Analysis

Assaydevelopment

Lead optimization


QA/QC

LC MS solutions

2008

Clavulanic Acid and Amoxicillin in Plasma

Assaydevelopment

Lead optimization


QA/QC

Relative Concentration-0.5 0 0.5 1 1.5 2 2.5 3 3.5 4 4.5 5 5.5 6 6.5 7 7.5 8 8.5 9 9.5 10 10.5

0

0.2

0.4

0.6

0.8

1

1.2

1.4

1.6

1.8

2

Rel

ativ

e R

espo

nses

y = 0.2057 * xR2 = 0.99989794

LLOQ: 10.1 pg/µL Amoxicillin in Plasma

Abundance vs. Acquisition Time (min)

x104

0

0.25

0.50

0.75

1.00

1.25

1.50

1.75

0.4 0.5 0.6 0.7 0.8 0.9 1.0 1.1 1.2

Relative Concentration0 1 2 3 4 5 6 7 8 9 10 11 12 13

-4x10

-0.250

0.250.5

0.751

1.251.5

22.25

2.52.75

33.25

3.754

4.254.5

4.75

Rel

ativ

e R

espo

nses

x103

0

0.1

0.2

0.3

0.4

0.5

0.6

0.7

0.8

0.9

1.0

1.1

1.2

1.3

1.4

1.5

1.6

Abundance vs. Acquisition Time (min)0.05 0.1 0.15 0.2 0.25 0.3 0.35

0.05 ng/µL0.25 ng/µL0.50 ng/µL

1.75

3.5

y = 4.1936E-005 * x - 2.7931E-007R2 = 0.99474559

LLOQ: 0.05 ng/µL Clavulanic Acid in Plasma

2.50 ng/µL

5.00 ng/µL

LCMS solutions

2008

Results – Plasma concentrations

µg*h/mLµg/(mL*h)hµg/mLµg*h/mL

4.24±14.66AUC ∞

0.03±0.41kElim

0.18±1.00Tmax

1.33±4.00Cmax

3.30±14.17AUC

µg*h/mLµg/(mL*h)hµg/mLµg*h/mL

1.27±6.60AUC ∞

0.06±0.39kElim

0.38±1.00Tmax

1.35±2.57Cmax

1.17±5.98AUC

Amoxicilline Clavulanic Acid

Amoxicilline / Clavulanic Acid

0.0

1.0

2.0

3.0

4.0

5.0

6.0

7.0

0.00 1.00 2.00 3.00 4.00 5.00 6.00 7.00 8.00 9.00Time [h]

Con

cent

ratio

n [µ

g/m

L]

Clav_AverageClav_1

Clav_2

Clav_3

Clav_4

Clav_5

Amox_AverageAmox_1

Amox_2

Amox_3

Amox_4

Amox_5

LC MS solutions

2008

Fast Method setup with MassHunter Software

Assaydevelopment

Lead optimization


QA/QC

Method set-up tasks

Sample Information(TIC of all compounds)

Compound Information(Target, ISTD; Quantifier, Qualifier)

MRM information for Quantifier, Qualifier, ISTD information, etc. directly pulled from acquisition method! (Additional columns

available for all available tasks)

LC MS solutions

2008

Compliance in Aquisition and Processing

Assaydevelopment

Lead optimization


QA/QC

LC MS solutions

2008

Drug development LC MS applications

Assaydevelopment

Lead optimization


QA/QC

Command Rolerequires

requires

LC MS solutions

2008

MassHunter compliance: Audit trail

Audit trail records support compliance

Saves heavy-lifting of logging actions

Batch-oriented

Audit Trail viewer: Sorting, Filtering, GroupingPrint, Print Preview, Export to Excel

Actions audited:CommandUserTimeReasonCommentSuccessErrorSession

Quant Audit trail: Configurable Powerful UI

Assaydevelopment

Lead optimization


QA/QC

LC MS solutions

2008

Supporting ComplianceSecurity, Audit Trail and Configurable Roles

Security:Acquisition DataAnalysis ResultsReporting ResultsTamper Detection

Quant Audit trail: Configurable Excel-like Viewer

RolesIdentify user Action requires RoleConfigurable

Assaydevelopment

Lead optimization


QA/QC

LC MS solutions

2008

Degradation products in a formulation batchwith 6310 Ion Trap MS

Assaydevelopment

Lead optimization


QA/QC

1

4

23 5

0.0 2.5 5.0 7.5 10.0 12.5 15.0 17.5 Time [min]0

1

2

3

6x10

Intens.

35

0 2 4 6 8 10Time [min]0.0

0.5

1.0

1.55x10

Intens.

1) amoxicillin, EIC 3662) amoxicillin penicilloic acid, EIC 3843) amoxicillin penilloic acid I and II, EIC 3404) 4-hydroxyphenylglycyl amoxicillin, EIC 5155) diketopiperazine amoxicillin, EIC 366

19.37diketopiperazinamoxicillin1.6336.6610.4

0.834-hydroxyphenylglycyl amoxicillin

0.761.589.3

1.77amoxicillin penilloicacid I or II1.313.358.1

1.02amoxicillin penilloicacid I or II0.591.936.9

100.00amoxicillin39.35189.194.3

12.81amoxicillin penicillioc acid7.5924.242.5

Ratio compared to amoxicillin [%]CompoundHeight

[*105]Area [*106]RT [min]

LC MS solutions

2008

Extracted ion chromatograms of amoxicillin degradation products and identification by MS/MS in MRM mode

0.0 2.5 5.0 7.5 10.0 12.5 15.0 17.5 Time [min]0

1

2

3

46x10

Intens.

NH

O

H NH2 NO

SH

CH3

CH3

H COOH

H

OH

EIC 366 +All MSn

OH

NH

NH

O

O

NH

S

CH3

CH3

H COOH160.0

348.9 +MS2, (366.0),4.0min

0

12

7x10Intens.

100 150 200 250 300 350 400 450 500 550 m/z

114.0

160.0

207.0

+MS2(366.0), 10.8min

01236x10

Intens.

100 150 200 250 300 350 400 450 500 550 m/z

A B

C

Assaydevelopment

Lead optimization


QA/QC

LC MS solutions

2008

Identification of minor impurities in a drug by 6210 TOF(main compound: [M+H]+ C16H26NO2, m/z 264.1964)

Assaydevelopment

Lead optimization


QA/QC

min5 10 15 20 25

mAU

-0.5

0

0.5

1.0

1.5

2.0

2.5

3.0

Main compound

ADB + C

1.2-0.3250.1804250.1807C15H24NO2D

2.9-0.7246.1851246.1858C16H24NOC

3.2-0.8246.1850246.1858C16H24NOB

2.5-0.7264.1957264.1964C16H26NO2A

Mass accuracy [ppm]

Mass accuracy [mDa]

Measured mass

Calculated massFormulaImpurity

1.2-0.3250.1804250.1807C15H24NO2D

2.9-0.7246.1851246.1858C16H24NOC

3.2-0.8246.1850246.1858C16H24NOB

2.5-0.7264.1957264.1964C16H26NO2A

Mass accuracy [ppm]

Mass accuracy [mDa]

Measured mass

Calculated massFormulaImpurity

O CH3

Br

OH

HN

CH3CH3

O CH3

OH

HN

CH3CH3

O CH3

NCH3CH3

H

O

+

Main compound

Impurity AImpurity E

Bromanisole

(Impurity F)

NCH3CH3

O CH3

NCH3CH3

O CH3

HN

CH3CH3

OH

H

OH

Impurity B Impurity C Impurity D

LC MS solutions

2008

Universal Internal Reference MassGas Phase Addition of Calibrant Masses

• Calibrant Delivery System delivers low flow rate calibration solutions into APCI, APPI, MM sources.

• Solution volatilizes and introduces and calibration masses in the gas phase ionize

• No Software changes needed

Stainless steel delivery tube connects via Union to CDS

Assaydevelopment

Lead optimization


QA/QC

LC MS solutions

2008

Production Monitoring Four 6100 Series SQ Models

6110• SIM sensitivity = 10 pg > 20:1 reserpine.• Mass range: 10 – 1500 m/z.• No positive/negative switching.

6120• SIM sensitivity = 10 pg > 20:1 reserpine.• Mass range: 10 – 1500 m/z.• Fast positive/negative switching.• Multi signal acquisition.• Divert valve.

6130• Scan sensitivity = 50 pg > 20:1 reserpine.• SIM sensitivity = 1 pg > 20:1 reserpine.• Mass range: 10 – 3000 m/z.• Fast positive/negative switching.• Multi signal acquisition.• Divert valve.

6140• Scan sensitivity = 50 pg > 20:1 reserpine.• SIM sensitivity = 1 pg > 20:1 reserpine.• Mass range: 10 – 1350 m/z.• Fast positive/negative switching.• Multi signal acquisition.• Scan speed at 10 KDa/s • Divert valve.

Assaydevelopment

Lead optimization


QA/QC

LC MS solutions

2008

HPLC-Chip Platform SupportSupporting Workflows from Discovery to Verification

Introduced with Integrated nano-ESIon Ion Trap for Protein ID

Reference Mass Introduction for Ultimate Mass Accuracy on TOF &

QTOF Biomarker Discovery/ Metabolite ID

Integrated with Agilent’s Triple Quadfor Ultimate Sensitivity and

Quantification

Assaydevelopment

Lead optimization


QA/QC

LC MS solutions

2008

LC/MS Systems for Drug Research

6510 QTOF Ultimate MS/MS system value with high analytical performance for accurate mass based structural elucidation, and metabolite ID in drug discovery

6210 TOFHigh throughput walk up accurate mass system for compound screening and confirmation

6410 Triple QuadrupoleHigh sensitivity MS/MS system for quantitative analysis in drug metabolism and pharmacokinetic studies (DMPK)

6300 Series Ion Traps High sensitivity MSn workhorse for compound identification and structural elucidation in drug discovery and early ADMET

6100 Series Single QuadEasy to use high selectivity MS system for routine quantitationand use in QA/QC

1200 Series LC and Rapid Resolution System

Assaydevelopment

Lead optimization


QA/QC

LC MS solutions

2008

Assaydevelopment

Lead optimization


QA/QC

All the Performance. All the Time.All the Performance. All the Time.

01-lcms solutions for drug research in the pharmaceutical

Documents